adamfeuerstein
$ONXX carfilzomib+MP in elderly naive myeloma. Small, early trial but 89% ORR called "very promising." #ASC012
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.